S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co.|
|FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq™ (belinostat) for Injection|
|Spectrum Pharmaceuticals Announces Second Quarter 2014 Financial Results Teleconference and Webcast (2014/7/31)|
|Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York City on September 9th (2014/9/2)|
|Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster (2014/8/7)|
|Spectrum Pharmaceuticals granted accelerated approval of lymphoma treatment|
|Ligand Reports Second Quarter 2014 Financial Results|
|Ligand Partner GSK Announces the Start of a Phase 3 Study with Eltrombopag in Patients with Myelodysplastic Syndromes|
|TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4|
|Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million|
Click above to view more mutual fund data and stats for sppi - Spectrum Pharmaceuticals Inc.